FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formula I.
.
EFFECT: technical result is obtaining novel compounds having affinity for TAAR1 receptor, which can be used for treating mediated diseases.
15 cl, 1 tbl, 121 ex
Title | Year | Author | Number |
---|---|---|---|
2-OXA-5-AZABICYCLO[2.2.1]HEPTANE-3-YL DERIVATIVES | 2015 |
|
RU2697651C2 |
SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
SUBSTITUTED BENZAMIDE DERIVATIVES | 2010 |
|
RU2595902C2 |
SUBSTITUTED THIOPHENECARBOXAMIDES AND ANALOGUES AS ANTIBACTERIAL AGENTS | 2019 |
|
RU2797513C2 |
SUBSTITUTED THIOPHENECARBOXAMIDES AND ANALOGUES AS ANTIBACTERIAL AGENTS | 2019 |
|
RU2797316C2 |
SUBSTITUTED THIOPHENECARBOXAMIDES AND ANALOGUES AS ANTIBACTERIAL AGENTS | 2019 |
|
RU2799335C2 |
QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS AND USE THEREOF | 2012 |
|
RU2610262C2 |
COMPOUNDS OF PYRIDAZINAMIDE AND THEIR USE AS SYNTHETIC SYNECKINASIS INHIBITORS (SYK) | 2013 |
|
RU2627661C2 |
PYRAZOLE-BASED MAGL INHIBITORS | 2018 |
|
RU2789157C2 |
HETEROCYCLIC DERIVATIVES AS RECEPTORS ASSOCIATED WITH TRACER AMINES (TAARS) | 2013 |
|
RU2621050C2 |
Authors
Dates
2019-05-31—Published
2015-04-27—Filed